These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19496117)

  • 1. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: is it safe?
    Veselka J
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):520-1; author reply 522. PubMed ID: 19496117
    [No Abstract]   [Full Text] [Related]  

  • 2. The problem of orphan procedures: Comment on "sudden cardiac death complicating alcohol septal ablation: a case report and review of literature".
    Tobis J
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):960. PubMed ID: 19455562
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden death after alcohol septal ablation in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED; Meditskou S; Pliakos C; Styliadis IH; Parcharidis GE
    Am J Cardiol; 2009 Sep; 104(5):743. PubMed ID: 19699364
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death complicating alcohol septal ablation: a case report and review of literature.
    Antoun P; El Masry H; Breall JA
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):956-9. PubMed ID: 19133681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Golden jubilee of hypertrophic cardiomyopathy: is alcohol septal ablation the gold standard?
    Parakh N; Bhargava B
    Cardiovasc Revasc Med; 2009; 10(3):172-8. PubMed ID: 19595399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic rounds series II: hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy.
    Kern MJ; Rajjoub H; Bach R
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):221-8. PubMed ID: 10376511
    [No Abstract]   [Full Text] [Related]  

  • 10. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
    Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
    Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
    [No Abstract]   [Full Text] [Related]  

  • 11. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.
    Cheng TO
    Circulation; 2004 Jul; 110(3):e23; author reply e23. PubMed ID: 15262858
    [No Abstract]   [Full Text] [Related]  

  • 12. New trends in treatment of hypertrophic cardiomyopathy.
    Hagège AA; Desnos M
    Arch Cardiovasc Dis; 2009 May; 102(5):441-7. PubMed ID: 19520330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Haghjoo M
    J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: novel application of the cutting balloon.
    Polin N; Feldman D; Naidu SS
    J Invasive Cardiol; 2006 Sep; 18(9):436-7. PubMed ID: 16954586
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Hori Y; Ueda M; Nakayama T; Saegusa N; Uehara M; Lee K; Sekine T; Daimon M; Kobayashi Y; Funabashi N; Komuro I
    Int J Cardiol; 2007 Jul; 119(3):403-7. PubMed ID: 17069908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance for the assessment of the effects of alcohol septal ablation in hypertrophic cardiomyopathy.
    Kornacewicz-Jach Z; Wojtarowicz A; Goos H; Schulz-Menger J; Goracy J; Płońska E; Przybycień K
    Kardiol Pol; 2004 Nov; 61(11):461-7. PubMed ID: 15883594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings.
    Yacoub MH
    Circulation; 2005 Jul; 112(4):450-2. PubMed ID: 16043655
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 20. Alcohol ablation of the intraventricular septum in symptomatic patients with hypertrophic obstructive cardiomyopathy.
    Mayes CE; Wang A; Warner JJ; Krasuski RA; Kisslo KB; Bashore TM; Harrison JK
    N C Med J; 2002; 63(3):136-40. PubMed ID: 12181848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.